UnitedHealth Group Incorporated $UNH Shares Sold by ProShare Advisors LLC

ProShare Advisors LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 240,582 shares of the healthcare conglomerate’s stock after selling 1,946 shares during the period. ProShare Advisors LLC’s holdings in UnitedHealth Group were worth $88,313,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Vise Technologies Inc. boosted its stake in UnitedHealth Group by 24.5% during the third quarter. Vise Technologies Inc. now owns 51,505 shares of the healthcare conglomerate’s stock worth $18,906,000 after acquiring an additional 10,125 shares in the last quarter. Investment Partners LTD. raised its position in shares of UnitedHealth Group by 69.2% during the third quarter. Investment Partners LTD. now owns 851 shares of the healthcare conglomerate’s stock worth $313,000 after purchasing an additional 348 shares during the period. Cidel Asset Management Inc. lifted its holdings in shares of UnitedHealth Group by 0.9% in the 3rd quarter. Cidel Asset Management Inc. now owns 13,323 shares of the healthcare conglomerate’s stock worth $4,891,000 after purchasing an additional 125 shares in the last quarter. Blue Fin Capital Inc. grew its position in UnitedHealth Group by 0.6% in the 3rd quarter. Blue Fin Capital Inc. now owns 16,352 shares of the healthcare conglomerate’s stock valued at $6,003,000 after purchasing an additional 98 shares during the period. Finally, Summit Global Investments increased its stake in UnitedHealth Group by 48.3% during the 3rd quarter. Summit Global Investments now owns 7,944 shares of the healthcare conglomerate’s stock valued at $2,916,000 after purchasing an additional 2,588 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $406.67 on Monday. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The stock’s fifty day simple moving average is $390.20 and its two-hundred day simple moving average is $362.40. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The stock has a market cap of $365.02 billion, a PE ratio of 23.23, a price-to-earnings-growth ratio of 1.47 and a beta of 0.51.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.70 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business’s revenue was down .4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were given a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio is presently 53.00%.

Analyst Ratings Changes

Several research firms have weighed in on UNH. Bank of America restated a “buy” rating and set a $450.00 price objective on shares of UnitedHealth Group in a report on Monday, July 20th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $370.00 to $467.00 and gave the company a “hold” rating in a report on Friday, July 17th. Wall Street Zen raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Jefferies Financial Group upped their target price on shares of UnitedHealth Group from $401.00 to $490.00 and gave the stock a “buy” rating in a report on Friday, July 17th. Finally, Zacks Research cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 14th. Twenty analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $463.93.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.19% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.